Posts

New Research Connects Frailty to Increased Five-Year Mo...

A groundbreaking study published in JAMA Network Open highlights the critical co...

Revolutionary Antiviral Chewing Gum Aims to Curb Transm...

In a distinct leap forward in antiviral research, scientists from the University...

Upcoming Insights: Journal of Nuclear Medicine Tip Shee...

Novel Approaches in Oncology and Imaging: Unveiling the Latest Research from The...

Research Indicates Poorer Patient Outcomes in Hospitals...

In a pivotal study recently published in the esteemed journal Nursing Research, ...

Study Uncovers the Reasons Behind Young Plants’ Suscept...

A recent breakthrough research from University of Maryland sheds light on a long...

UNM Researchers Uncover Mechanism of Toxic Metal Nanopa...

University of New Mexico researchers have recently unveiled alarming new finding...

CBN: 10 Benefits Of This Brain-Friendly Cannabinoid

When you think of cannabis compounds, CBD and THC probably come to mind first. B...

Roche Reports Promising Early Data on Alzheimer’s Drug ...

Roche has disclosed preliminary findings regarding its investigational Alzheimer...

FDA Gives Reproxalap the Red Light For Dry Eye Disease

The US Food and Drug Administration has sent a second detailed reaction letter t...

FDA awards ODD status to Sanofi’s rilzabrutinib for two...

Sanofi's reversible BTK inhibitor rilzabrutinib has gained the US Food and Drug ...

Neurona raises $102m to advance cell therapy for drug-r...

Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in ...

IO360 Summit: Improving CAR-T cell therapy manufacture ...

If preclinical findings were translated into the clinic, they could shorten the ...

AD/PD 2025: DHTs can detect disease progression in pati...

At AD/PD 2025, Roche outlined how digital health technologies (DHTs) provide mor...

ABPI calls on UK Government to resolve “VPAG crisis”

UK Government drug sale clawbacks must be eased for pharma innovation to meet it...

Atsena closes $150m in Series C round to progress gene ...

Atsena Therapeutics has completed an oversubscribed Series C financing round, ra...

IO360 summit: CAR-T cell therapy applications beyond bl...

Recent innovations include engineering CAR T-cells to overcome the immunosuppres...